Tinubu Signs Executive Order, Stops Tax on imported Pharmaceutical Inputs


President Bola Tinubu has signed an executive order to introduce zero tariffs, excise duties and value added tax (VAT) on imported pharmaceutical inputs.


This was disclosed by the coordinating minister of health and social welfare, Muhammad Ali Pate, in a statement on Friday, June 28, 2024.


“In a transformative move to revitalize the Nigerian health sector, His Excellency President Bola Ahmed Tinubu, GCFR @officialABAT, has signed an Executive Order aiming to increase local production of healthcare products (pharmaceuticals, diagnostics, devices such as needles and syringes, biologicals, medical textile, etc.).

Also Read:  APC Chieftain, Rasaq Raji Denies Conduct of Reps Primary in Olorunsogo, Warns Against ‘False Claims’


The Minister of Justice and Attorney General of the Federation @FedMinOfJustice, Prince Lateef Olasunkanmi Fagbemi SAN, @LOFagbemi, is to now take the next steps towards codifying the new Order.


The Order introduces zero tariffs, excise duties and VAT on specified machinery, equipment and raw materials, aiming to reduce production costs and enhance our local manufacturers’ competitiveness.

Also Read:  Internet Fraudster Sentenced To Six Months Of Community Service In Ibadan


Specified items include Active Pharmaceutical Ingredients (AP|s), excipients, other essential raw materials required for manufacturing of crucial health products like drugs, syringes and needles, Long-lasting Insecticidal Nets (LLINs) and Rapid Diagnostic Kits, among others.


The Order also provides for establishing market shaping mechanisms such as framework contracts and volume guarantees, to encourage local manufacturers.

Also Read:  Makinde approves Reconstruction of 23km Okaka-Igbojaye Road


The implication of this order is pivot towards market-based incentives to encourage medical industrialization, reducing costs of medical products through import substitution over time, creating and retaining economic value and enabling job creation in the healthcare value chain,” the minister said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Don't Miss

Categories

Tinubu Signs Executive Order, Stops Tax on imported Pharmaceutical Inputs


President Bola Tinubu has signed an executive order to introduce zero tariffs, excise duties and value added tax (VAT) on imported pharmaceutical inputs.


This was disclosed by the coordinating minister of health and social welfare, Muhammad Ali Pate, in a statement on Friday, June 28, 2024.


“In a transformative move to revitalize the Nigerian health sector, His Excellency President Bola Ahmed Tinubu, GCFR @officialABAT, has signed an Executive Order aiming to increase local production of healthcare products (pharmaceuticals, diagnostics, devices such as needles and syringes, biologicals, medical textile, etc.).

Also Read:  We Endorsed Aluko, Not Ajimobi As Deputy National Chairman — Ekiti APC


The Minister of Justice and Attorney General of the Federation @FedMinOfJustice, Prince Lateef Olasunkanmi Fagbemi SAN, @LOFagbemi, is to now take the next steps towards codifying the new Order.


The Order introduces zero tariffs, excise duties and VAT on specified machinery, equipment and raw materials, aiming to reduce production costs and enhance our local manufacturers’ competitiveness.

Also Read:  We Are Ready To Foster Peace In Oyo PDP If..., Aggrieved Party Members Tell Arapaja


Specified items include Active Pharmaceutical Ingredients (AP|s), excipients, other essential raw materials required for manufacturing of crucial health products like drugs, syringes and needles, Long-lasting Insecticidal Nets (LLINs) and Rapid Diagnostic Kits, among others.


The Order also provides for establishing market shaping mechanisms such as framework contracts and volume guarantees, to encourage local manufacturers.

Also Read:  FoodCo, Kilimanjaro, Other Outlets Reject Old Naira Notes in Ibadan


The implication of this order is pivot towards market-based incentives to encourage medical industrialization, reducing costs of medical products through import substitution over time, creating and retaining economic value and enabling job creation in the healthcare value chain,” the minister said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_imgspot_img
spot_img

Don't Miss

Categories

Related Articles